Pharmaceutical Control of the
Human Microbiome

Symberix CEO Presents at Translational Microbiome Conference

June 2015

Dr. Ward Peterson delivered a presentation entitled “When Good Bugs Do Bad Things: Targeting the Microbiome to Make Better Human Genome-Targeted Drugs” at the annual Translational Microbiome Conference on May 14, 2015 in Boston. The Conference focused on the potential for translational interventions in microbiome research and the challenges the industry will need to address to make this space successful. Leading academic and industry experts explored the current state of translational microbiome research in therapeutic areas including pulmonology, immunology, oncology and dermatology. For more information, click here Translational Microbiome Conference.

 

 


Back to News